Edgewell Personal Care

Edgewell reported Q3 fiscal 2026 net sales of $570.1 million, with organic sales up 1.1% and North America organic growth of 3.0% driven by Sun, Skin Care and Grooming. Gross and adjusted margins compressed as advertising, SG&A and $24.5 million in restructuring charges pushed operating income down to $25.0 million from $45.0 million and GAAP EPS to $0.26. The company narrowed its full-year outlook while raising restructuring costs to about $92 million, leaving recovery dependent on sustained North American momentum amid international disruption and Wet Shave weakness. » More on finance.yahoo.com

At the Barclays conference Edgewell said the multi-year restructuring is largely complete and the company is now entering a growth and simplification phase. North America showed organic growth in the third quarter, market share was regained, and management expects the fourth quarter to be the strongest of the year for organic revenue growth and gross margin. Going forward the company will focus on automation, system harmonization and the use of AI, while plant consolidations, tariffs and higher raw material costs are causing short-term headwinds. After the sale of the feminine care business, Edgewell sees greater financial flexibility and expects free cash flow to improve once one-off costs subside. » More on de.investing.com

Edgewell reported Q3 fiscal 2026 organic net sales growth driven by improved North America performance and strength in Sun Care, Grooming and branded Wet Shave. Adjusted EPS and adjusted EBITDA exceeded expectations while adjusted gross margin was in line with guidance; management expects stronger Q4 and left full‑year adjusted EPS and EBITDA midpoint unchanged. Company highlighted progress from its Feminine Care divestiture, expanded brand investments (Hawaiian Tropic, Cremo, Billie), and ongoing Wet Shave manufacturing consolidation to drive future productivity, margin and cash flow improvements. » More on finance.yahoo.com